FFP
TMO icon

FourThought Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History

FourThought Financial Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.63M Buy
11,223
+539
+5% +$259K 0.43% 63
2026
Q1 		$5.25M Buy
10,684
+470
+5% +$255K 0.45% 63
2025
Q4 		$5.92M Buy
10,214
+2
+0% +$1.13K 0.5% 56
2025
Q3 		$4.95M Buy
10,212
+58
+0.6% +$27K 0.44% 66
2025
Q2 		$4.12M Buy
10,154
+371
+4% +$155K 0.41% 68
2025
Q1 		$4.87M Buy
9,783
+243
+3% +$132K 0.51% 57
2024
Q4 		$4.96M Buy
9,540
+35
+0.4% +$19.2K 0.52% 56
2024
Q3 		$5.88M Buy
9,505
+55
+0.6% +$32.6K 0.7% 51
2024
Q2 		$5.23M Buy
9,450
+149
+2% +$85.4K 0.67% 49
2024
Q1 		$5.41M Sell
9,301
-114
-1% -$64K 0.62% 47
2023
Q4 		$5M Sell
9,415
-276
-3% -$134K 0.63% 48
2023
Q3 		$4.91M Buy
9,691
+2,023
+26% +$1.08M 0.69% 45
2023
Q2 		$4M Buy
7,668
+1,239
+19% +$669K 0.53% 56
2023
Q1 		$3.71M Buy
6,429
+952
+17% +$537K 0.51% 60
2022
Q4 		$3.02M Buy
+5,477
New +$2.9M 0.44% 66

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FourThought Financial Partners's TMO Position: Q2 2026 in Review

FourThought Financial Partners increased its Thermo Fisher Scientific (TMO) stake by 5% in Q2 2026, buying an estimated $259K and bringing the position to 11,223 shares worth $5.63M. The position accounts for 0.43% of the portfolio, ranked #63.

FourThought Financial Partners first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.92M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • FourThought Financial Partners held 11,223 shares of Thermo Fisher Scientific worth $5.63M as of Q2 2026.
  • FourThought Financial Partners bought 539 Thermo Fisher Scientific shares in Q2 2026, an estimated $259K.
  • Thermo Fisher Scientific made up 0.43% of FourThought Financial Partners's portfolio in Q2 2026, its #63 holding.
  • FourThought Financial Partners first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • FourThought Financial Partners's Thermo Fisher Scientific position peaked at $5.92M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on FourThought Financial Partners's 13F filing for Q2 2026, filed 12 Aug 2026.